Biotechs That Soared in 2012: Top Performers Average Gain of 314%
DESCRIPTION
Explore the top-performing biotech companies of 2012 with an average gain of 314%. Companies like Arena Pharmaceutical, Celsion Corp, Acadia Pharmaceutical, and more saw remarkable increases in their stock values. Learn about these successful biotechs and their significant growth in the market.
1 / 12
Télécharger la présentation
Biotechs That Soared in 2012: Top Performers Average Gain of 314%
An Image/Link below is provided (as is) to download presentation
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.
Content is provided to you AS IS for your information and personal use only.
Download presentation by click this link.
While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
During download, if you can't get a presentation, the file might be deleted by the publisher.
E N D
Presentation Transcript
Top Performing Biotechs ~ 2012 AVERAGE GAIN 314%
Average Gain 314% • 1. Arena Pharmaceutical (ARNA) +560% • 2. Celsiun Corp (CLSN) +438% • 3. Acadia Pharmaceutical (ACAD) +369% • 4. SareptaTheraputics (SRPT) +360% • 5. BioMimeticTherpapiutics (BMTI) +309% • 6. ReprosTheraputics (RPRX) +259% • 7. OrexigenTherputics (OREX) +223% • 8. Sunesis Pharmaceuticals (SNSS) +216% • 9. Threshold Pharmaceuticals (THLD) +208% • 10. Affymax Inc. (AFFY) +204%
More Related